[Prediction of the effectiveness of levamisole immunotherapy by the sensitivity of blood lymphocytes to the drug].
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000328:Adult; D002675:Child, Preschool; D002908:Chronic Disease; D004341:Drug Evaluation; D006801:Humans; D007153:Immunologic Deficiency Syndromes / Q000188:drug therapy / Q000276:immunology; D066298:In Vitro Techniques; D007223:Infant; D007978:Levamisole / Q000627:therapeutic use*; D011379:Prognosis; D012130:Respiratory Hypersensitivity / Q000188:drug therapy / Q000276:immunology; D012397:Rosette Formation; D013601:T-Lymphocytes / Q000187:drug effects* / Q000276:immunology
D000276:Adjuvants, Immunologic; D007978:Levamisole
Prognozirovanie éffektivnosti immunoterapii levamizolom po chuvstvitel'nosti k nemu limfotsitov krovi.